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The benzofuran scaffold is ubiquitous in the area of pharmacologically active agents and isolated 
natural products. Natural products possessing the 2-substituted moiety exhibit a broad range of 
pharmacological activities such as antimicrobial, anti-inflammatory, antifungal, antipsychotic, 
antilipidemic, analgesic, cytotoxic and central nervous system
 
stimulant. Also, benzofuran nucleus 
has been recently described as a good scaffold for designing potent and relatively non-selective 
MAOIs.  
The synthesis and identification of novel 2-eteroarylbenzofuran derivatives with electron-
donating and electron-withdrawing substituents are reported in this work.  
The key step for the formation of the benzofuran moiety was achieved by an intramolecular 
Wittig reaction between ortho-hydroxybenzyltriphosphonium salts and the appropriate aroyl 
chlorides. 
Their complete structural characterization was performed using one-dimensional and two- 
dimensional resonance techniques. The acquired data constitute a valuable database for the 
unambiguous identification of eteroarylbenzofuran library developed with the aim of our medicinal 
chemistry program. 
 




Many important biochemical compounds and drugs of natural origin contain heterocyclic ring 
structures. The presence of heterocyclic structure in such different type of compounds is strongly 
indicative of the diverse pharmacological activities and recognition of this is reflected in efforts to 
find useful synthetic drugs. 
The benzofuran ring system itself is a common structure element that appears in a large number 
of medicinally important compounds.
1
 Widespread interest in the chemistry of benzofurans in a 
large number of natural products has attracted due to their biological activities and their potential 
application as pharmacological agents.
2 
 
Various benzofuran derivatives possess different pharmacological and biological activities of 
which the most potent is anti-inflammatory, pesticidal e insecticidal, antihistaminic, anticonvulsant, 
antiallergic. In vitro-HIV-1, anticancer, anti-microbial activities.
3,4
 
Also, benzofuran nucleus has been recently described as a good scaffold for designing potent and 
relatively non-selective MAO inhibitors.
 5,6
 
In the present work a series of 2-eteroarylbenzofurans (Figure 1) were synthesized and their 








Results and discussion 
 
Compounds 1–8 were efficiently synthesized according to the synthetic strategy outlined in 
Scheme 1. The key step for the formation of the benzofuran moiety was achieved by an 




The desired Wittig reagent was readily prepared from the conveniently substituted ortho-
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Scheme 1. Reagents and conditions: toluene, NEt3, 110°C, 2h 
 
The benzofurans structure were confirmed by mass spectrometry, elemental analyses, one-
dimensional and two- dimensional resonance techniques. In table 1 we reported yields and mp 
obtained for compound 1-8. 
 
compounds Yeld Mp 
1 60% 78-80 °C 
2 17% 109-111 °C 
3 40% 116-118 °C 
4 10% 129-131 °C 
5 23% 128-130 °C 
6 10% 186-188 °C 
7 15% 154-156 °C 
8 15% 144-146 °C 
 














Materials and Methods 
 
Starting materials and reagents were obtained from commercial suppliers and were used without 
purification. Melting points (mp) are uncorrected and were determined with a Reichert Kofler 
thermopan or in capillary tubes in a Buchi 510 apparatus. 
1
H NMR and 
13
C NMR spectra of the samples, approximately 10% solutions in deuterated 
dimethyl sulfoxide, were recorded with at room temperature in 5-mm-outer-diameter tubes. TMS 
was used as internal standard, and chemical shifts are expressed in parts per million (δ) and J in 
hertz. 1D 
13
C NMR was recorded on a Bruker AMX 500 NMR spectrometer operating at 125.77 
MHz, typically with a 30◦ pulse flip angle, a pulse repetition time of 4.8 s, and a spectral width of 
31.250 Hz with 32K data points. For the DEPT sequence, the width of the 90◦ pulse for 
13
C was4 
µs, and that of the 90◦ pulse for 
1
H was 9.5 µs; the delay 2JC,H was set to 3.5 ms. One-bond HMQC 
spectra were recorded on a Bruker AMX 500 spectrometer using pulse sequence that allowed 
gradient selection (Bruker programs INV4GS and INVGSLPLRND). The spectra were collected in 
the t1 domain in 256 experiments with 2 K data points and spectral widths of 5.050 and 27 669 Hz 
in the F2 (
1
H) and F1 (
13
C) dimensions, respectively. The relaxation delay D1 was set to 2s. The data 
were processed using sine-bell weighting functions in both dimensions. 
Mass spectrometry was carried out with a Hewlett-Packard 5988A spectrometer operating under 
EI conditions (electron energy 70 eV). Elemental analyses were performed using a Perkin-Elmer 
240B microanalyser and were within ± 0.4% of calculated values in all cases. Silica gel (Merk 60, 
230-00 mesh) was used for flash chromatography (FC). Analytical thin layer chromatography 




General procedure for the preparation of 2-hydroxybenzylalcohols: NaBH4 (6.60 mmol) was 
added to a stirring solution of 2-hy-droxybenzaldehyde (6.60 mmol) in EtOH (20 mL) in an ice 
bath. The reaction mixture was stirred at room temperature for 1 h. After that, the solvent was 
removed, 1n aqueous HCl (40 mL) was added to the residue and extracted with Et2O. The solvent 
was evaporated under vacuum to give the desired compounds  
 
General procedure for the preparation of 2-hydroxybenzyltri-phenylphosphonium bromide: A 
mixture of 2-hydroxybenzylalcohol (24.6 mmol) and PPh3·HBr (24.6 mmol) in CH3CN (50 mL) 
was stirred under reflux for 2 h. The solid that formed was filtered and washed with CH3CN to give 
the desired compounds. 
 
General procedure for the preparation of 2-aroylylbenzofuran: A mixture of 2-
hydroxybenzyltriphenylphosphonium bromide (1.10 mmol) and aroyl chloride (1.11 mmol) in a 
mixed solvent (toluene 20 mL and Et3N 0.5 mL) was stirred under reflux for 2 h. The precipitate 
was removed by filtration. The filtrate was concentrated, and the residue was purified by silica gel 




Novel 3-(2-benzofuran-2yl)-pyridine and 2-(2-benzofuran-2-yl)-quinoline derivatives with 
electron-donating and electron-withdrawing substituents in 5 position of the indole ring were 
obtained in moderate yields by intramolecular Wittig reaction. The compounds were further 
characterized by 1D and 2D NMR techniques that allowed full NMR signal assignments. The 
acquired data constitute a valuable database for the unambiguous identification of the benzofuran 
library developed with the aim of our medicinal chemistry program 
 
Acknowledgements 




1. S. E. Yoo, S. H. Lee, S. K. Kim, Bioorg. Med. Chem., 1997; 5, 445. 
2. F. A. W. Bakr, A. A. A. Hatem, M. A. Essam, Eur. Journal of Med. Chem., 2009; 44, 2632. 
3. L. Santana, M. Teijeira, E. Uriarte, C. Teran, Eur. J. Pharm. Sci., 1999, 7, 161. 
4. R. Madhu, M. D. Karvekar, S. Patel, S. Sarkar, Asian J. Chem., 2009, 21, 5151. 
5. L. H. A. Prins, J. P. Petzar, S. F. Malan, Eur. J. Med. Chem., 2010, 45, 4458. 
6. G. Ferino, E. Cadoni, M. J. Matos, E. Quezada, E. Uriarte, L. Santana, M. Yanez, D. Viña, C. Picciau, S. Serra, 
G. Delogu, Chem. Med. Chem., 2014, 9, 1672. 
7. A. Hercouet, M. Le Corre, Tetrahedron Lett., 1979, 23, 2145. 
8. M. Ono, H. Kawashima, A. Nonaka, T. Kaway, M. Haratake, H. Mori, M. P. Kung, H. F. Kung, H. Saji, M. 
Nakayama, J. Med. Chem., 2006, 49, 2725. 
9. M. Ono, M. P. Kung, C. Hou, H. F. Kung, Nucl. Med. Biol., 2002, 29, 633. 
